Skip Navigation


Carcinogenesis Advance Access originally published online on November 9, 2005
Carcinogenesis 2006 27(2):350-359; doi:10.1093/carcin/bgi264
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow An erratum has been published
Right arrow All Versions of this Article:
27/2/350    most recent
bgi264v2
bgi264v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mason, D. X.
Right arrow Articles by Lin, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, D. X.
Right arrow Articles by Lin, A. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis Vol.27 no.2 © Oxford University Press 2005; all rights reserved.

ARTICLES

Defined genetic events associated with the spontaneous in vitro transformation of ElA/Ras-expressing human IMR90 fibroblasts

Douglas X. Mason 1, 7, {dagger}, Daniel Keppler 3, 5, {dagger}, Jun Zhang 3, Tonya J. Jackson 1, Yvette R. Seger 6, 8, Seiichi Matsui 2, Fleurette Abreo 4, John K. Cowell 2, Gregory J. Hannon 6, Scott W. Lowe 6 and Athena W. Lin 1, *

1 Department of Pharmacology and Therapeutics and 2 Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA, 3 Department of Cellular Biology and Anatomy, 4 Department of Pathology and 5 Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA and 6 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
7 Present address: ZeptoMetrix Corporation, 872 Main Street, Buffalo, NY 14202, USA
8 Present address: FasterCures, The Center for Accelerating Medical Solutions, 509 7th Street, Washington, DC 20004, USA

* To whom correspondence should be addressed. Tel: +1 716 845 1548; Fax: +1 716 845 8857; E-mail: Athena.Lin{at}roswellpark.org.

In contrast to rodent cells, normal human fibroblasts are generally resistant to neoplastic transformation in vitro. Here, we report the derivation and characterization of a spontaneously transformed cell line from normal human IMR90 fibroblasts transduced with E1A and Ras oncogenes. Unlike the parental, non-tumorigenic E1A/Ras-expressing IMR90 cells, these spontaneously transformed cells displayed aberrant growth potential in vitro and were capable of tumorigenesis in vivo. In contrast to the parental E1A/Ras-expressing cells, both the spontaneously transformed cells and cells derived from resultant tumors displayed specific t(7q;8q) and t(5q;17) structural chromosomal changes. Chromosome 8q contains c-Myc, which is capable of activating the telomerase catalytic subunit hTERT. Notably, upregulation of c-Myc, hTERT and telomerase activity were detected only in the tumorigenic cells. Transduction of Myc siRNA into the tumorigenic cells led to a concomitant downregulation of hTERT. Furthermore, transduction of Myc or hTERT into the non-tumorigenic E1A/Ras-expressing IMR90 cells was able to confer tumorigenesis on these cells. These studies suggest that the t(7;8) translocation may result in Myc overexpression and its subsequent activation of hTERT, which may contribute to the tumorigenicity of the IMR90 cells. Furthermore, this report describes additional successful neoplastic transformation of human IMR90 fibroblasts by defined genetic elements. The spontaneously transformed cells we have derived provide a valuable model system for the study of neoplastic transformation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. L. Callejas-Valera, J. Guinea-Viniegra, C. Ramirez-Castillejo, J. A. Recio, E. Galan-Moya, N. Martinez, J. M. Rojas, S. R. y Cajal, and R. Sanchez-Prieto
E1a Gene Expression Blocks the ERK1/2 Signaling Pathway by Promoting Nuclear Localization and MKP Up-regulation: IMPLICATION IN v-H-Ras-INDUCED SENESCENCE
J. Biol. Chem., May 9, 2008; 283(19): 13450 - 13458.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Mahale, Z. A.T. Khan, M. Igarashi, G. J. Nanjangud, R. F. Qiao, S. Yao, S. W. Lee, and S. A. Aaronson
Clonal Selection in Malignant Transformation of Human Fibroblasts Transduced with Defined Cellular Oncogenes
Cancer Res., March 1, 2008; 68(5): 1417 - 1426.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Culver and S. M. Laster
Adenovirus Type 5 Exerts Multiple Effects on the Expression and Activity of Cytosolic Phospholipase A2, Cyclooxygenase-2, and Prostaglandin Synthesis
J. Immunol., September 15, 2007; 179(6): 4170 - 4179.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Li, A. W. Lin, X. Zhang, Y. Wang, X. Wang, and D. W. Goodrich
Cancer Cells and Normal Cells Differ in Their Requirements for Thoc1
Cancer Res., July 15, 2007; 67(14): 6657 - 6664.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.